Vose B M, Vánky F, Fopp M, Klein E
Br J Cancer. 1978 Sep;38(3):375-81. doi: 10.1038/bjc.1978.217.
Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions were only rarely detected (2/32 positive against lung and 1/13 positive against non-lung cells). The restriction of cytotoxicity to the autologous combination was also apparent in in vitro-generated effectors. Blood lymphocytes were co-cultivated with autologous tumour and subsequently tested against autologous or allogeneic targets. Cytotoxicity was found in 13/17 lung tumours against autologous tumour, with no reactions recorded against allogeneic tumour targets, but one case positive against the K562 cell line. These data suggest either the expression of individually distinct antigens on human pulmonary neoplasms, or the requirement for histocompatibility between target and effector in cytotoxicity reactions in man, and therefore differ from previously described patterns of lymphocytotoxicity against human tumours.
对47例肺癌患者的血液淋巴细胞进行了检测,以观察其对自肿瘤分离的细胞的细胞毒性。在15例中发现了显著的细胞毒性潜力。效应细胞还针对来自肺和其他部位的同种异体肿瘤靶标进行了检测。仅很少检测到反应(对肺肿瘤靶标32例中有2例阳性,对非肺细胞靶标13例中有1例阳性)。细胞毒性对自体组合的限制在体外产生的效应细胞中也很明显。血液淋巴细胞与自体肿瘤共同培养,随后针对自体或同种异体靶标进行检测。在17例肺肿瘤中有13例对自体肿瘤有细胞毒性,对同种异体肿瘤靶标未记录到反应,但有1例对K562细胞系呈阳性。这些数据表明,要么人类肺肿瘤上表达个体独特的抗原,要么人类细胞毒性反应中靶标与效应细胞之间需要组织相容性,因此与先前描述的针对人类肿瘤的淋巴细胞毒性模式不同。